New drug SKB571 aims to shrink GI tumors in early trial

NCT ID NCT07564466

Recruiting now Disease control Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This study tests a new drug called SKB571 in 120 adults with gastrointestinal tumors. The goal is to see if the drug can shrink tumors and how safe it is. Participants will receive the drug and be monitored for side effects and cancer progression. The study is not yet recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer digestive system neoplasm Digestive System Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL TUMORS

Contacts and locations

Locations

Cancer Hospital of Shandong First Medical University
RECRUITING

Jinan, Shandong, 250117, China
Chongqing University Three Gorges Hospital
RECRUITING

Chongqing, Chongqing Municipality, 404000, China
Fujian Cancer Hospital
NOT_YET_RECRUITING

Fuzhou, Fujian, 350014, China
Henan Cancer Hospital
NOT_YET_RECRUITING

Zhengzhou, Henan, 450008, China
Hunan Cancer Hospital
RECRUITING

Changsha, Hunan, 410013, China
Jiangsu Cancer Hospital
RECRUITING

Nanjing, Jiangsu, 210009, China
Jiangsu Province Hospital
RECRUITING

Nanjing, Jiangsu, 210029, China
Jiangxi Cancer Hospital
NOT_YET_RECRUITING

Nanchang, Jiangxi, 3300029, China
Renji Hospital, Shanghai Jiao Tong University School of Medicine
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200127, China
Shandong Provincial Hospital
RECRUITING

Jinan, Shandong, 250021, China
Shanxi Provincial Cancer Hospital
NOT_YET_RECRUITING

Taiyuan, Shanxi, 030013, China
Sichuan Cancer Hospital
NOT_YET_RECRUITING

Chengdu, Sichuan, 610041, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITING

Luoyang, Henan, 471003, China
The First Affiliated Hospital of Xiamen University
RECRUITING

Xiamen, Fujian, 361003, China
The First Affiliated Hospital of Zhengzhou University
RECRUITING

Zhengzhou, Henan, 450052, China
The First Hospital of China Medical University
NOT_YET_RECRUITING

Shenyang, Liaoning, 110001, China
The First Hospital of Jilin University
RECRUITING

Changchun, Jilin, 130021, China
The Fourth Hospital of Hebei Medical University
NOT_YET_RECRUITING

Shijiazhuang, Hebei, 050011, China
The People's Hospital of Guangxi Zhuang Autonomous Region
RECRUITING

Nanning, Guangxi, 530021, China
The Second Affiliated Hospital of Nanchang University
NOT_YET_RECRUITING

Nanchang, Jiangxi, 330006, China
The Second Affiliated Hospital of Xi'an Jiaotong University
RECRUITING

Xi'an, Shaanxi, 710004, China
The Sixth Affiliated Hospital, Sun Yat-sen University
NOT_YET_RECRUITING

Guangzhou, Guangdong, 510655, China
Tianjin Medical University Cancer Institute & Hospital
RECRUITING

Tianjin, Tianjin Municipality, 300060, China
Tumor Hospital of Harbin Medical University
NOT_YET_RECRUITING

Harbin, Heilongjiang, 150081, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.